-
S1 :
Improving Patient Access to Innovative Cancer Therapies: The Role of Managed Entry Agreements
-
S2 :
The Implementation of Sustainable Biosimilar Policies to Increase Access to Biological Medicines in CEE Countries
-
P1 :
Aligning Evidence Requirements for Drug Authorization and Coverage –Central and Eastern European (CEE) Countries Insights
-
P2 :
Health Data, Health Data, and More Health Data: From Quantity to Quality Through Cooperation
-
P3 :
Medical Device Assessment and Procurement - Fair and Efficient Access in Countries with Limited Health Budgets
-
P4 :
How Far Can We Go? Finding a Common Way in Clinical Evaluation, Data Generation, and Joint Procurement and Pricing Negotiations
